Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1202595013 | Chlorothiazide + methyldopa 250mg/250mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1215495013 | Chlorothiazide + methyldopa 250mg/250mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 1478650014 | Chlorothiazide+methyldopa 250mg/250mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3490432019 | Product containing chlorothiazide 250 mg and methyldopa 250 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3494242010 | Product containing chlorothiazide 250 mg and methyldopa 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501629011 | Chlorothiazide 250 mg and methyldopa 250 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3569206017 | Product containing only chlorothiazide 250 mg and methyldopa 250 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3569207014 | Product containing only chlorothiazide 250 mg and methyldopa 250 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3677502011 | Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3677503018 | Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Product containing methyldopa | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Methyldopa+diuretic | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has active ingredient | Methyldopa | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Product containing chlorothiazide and methyldopa | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has active ingredient | Chlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Product containing chlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has active ingredient | Centrally acting hypotensive agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Product containing methyldopa in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has active ingredient | Chlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Chlorothiazide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has active ingredient | Methyldopa | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has basis of strength substance | Methyldopa | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Methyldopa | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Has precise active ingredient | Chlorothiazide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Product containing chlorothiazide and methyldopa in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Is a | Product containing only chlorothiazide and methyldopa in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely chlorothiazide 250 milligram and methyldopa 250 milligram/1 each conventional release oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR